Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

MSCI Emerging Markets Index / Technical Analysis

Highlighted themes and actionable charts: Reiterating BRIC overweight. This country grouping continues to outperform broad EM, and we believe BRIC will be a primary source of outperformance relative to the MSCI EM Index moving forward.  Today’s report includes a wide variety of bottom-up recommendations, spanning most sectors and all market capitalizations within EM.

Highlighted themes and actionable charts: Reiterating BRIC overweight. This country grouping continues to outperform broad EM, and we believe BRIC will be a primary source of outperformance relative to the MSCI EM Index moving forward.  Today’s report includes a wide variety of bottom-up recommendations, spanning most sectors and all market capitalizations within EM.

EM Equity Strategy: Indonesia Perking Up; Overweight BRIC, Tech, and Health Care

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Xinte Energy (Xinte), a subsidiary of Shanghai listed TBEA (600089 CH), is said to be raising US$185m soon. Xinte is ranked second (with 13.3% market share) in the upstream polysilicon production in China and first in the downstream solar plant construction (Engineering, Procurement and Constrution, ie EPC, 6.3% market share by installed capacity).Xinte is raising capital to expand its downstream solar and wind plant in order to receive a more stable stream of income, thanks to favorable policy…

Xinte Energy (Xinte), a subsidiary of Shanghai listed TBEA (600089 CH), is said to be raising US$185m soon. Xinte is ranked second (with 13.3% market share) in the upstream polysilicon production in China and first in the downstream solar plant construction (Engineering, Procurement and Constrution, ie EPC, 6.3% market share by installed capacity).Xinte is raising capital to expand its downstream solar and wind plant in order to receive a more stable stream of income, thanks to favorable policy…

Xinte Energy IPO: Another Renewable Rush?

Hong Kong

GCL-Poly Energy Holdings Ltd is a Chinese power company that produces solar grade polysilicon and operates cogeneration plants and in China.

Gcl Poly Energy Holdings Limited (3800 HK)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Gcl Poly Energy Holdings Limited (3800 HK)

EM Equity Strategy: Indonesia Perking Up; Overweight BRIC, Tech, and Health Care

Highlighted themes and actionable charts: Reiterating BRIC overweight. This country grouping continues to outperform broad EM, and we believe BRIC...

Vermilion Research

Xinte Energy IPO: Another Renewable Rush?

Xinte Energy (Xinte), a subsidiary of Shanghai listed TBEA (600089 CH), is said to be raising US$185m soon. Xinte is ranked second (with 13.3%...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)